1 Min Read
NEW YORK, Jan 14 (Reuters) - Neuralstem Inc : * Jumps 15.3 percent to $1.43 in premarket after FDA ok’s spinal cord injury trial
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.